Bioinformatics processing of protein and transcript profiles of normal and transformed cell lines indicates functional impairment of transcriptional regulators in buccal carcinoma

Journal of Proteome Research

Volumn 6, Issue 9, 2007, Pages 3705-3717

  Staab, Claudia A ^a   Ceder, Rebecca ^a   Jägerbrink, Theres ^a   Nilsson, Jan Anders ^a   Roberg, Karin ^b   Jörnvall, Hans ^a   Höög, Jan Olov ^a   Grafström, Roland C ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cancer biomarkers; Cultured oral keratinocytes; Gene ontology; Molecular networks; Oral cancer; Proteomics; Serum free conditions; Transcription factors; Transcriptomics

Indexed keywords

ARTICLE; BIOINFORMATICS; CARCINOGENESIS; CELL LINE; CELL TRANSFORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEOMICS; TRANSCRIPTION REGULATION;

CELL LINE, TRANSFORMED; CHEEK; COMPUTATIONAL BIOLOGY; CULTURE MEDIA, SERUM-FREE; HUMANS; KERATINOCYTES; MODELS, MOLECULAR; MOUTH NEOPLASMS; PROTEINS; PROTEOMICS; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 34948892908     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr070308q     Document Type: Article

References (70)

1. La Vecchia, C.; Lucchini, F.; Negri, E.; Levi, F. Trends in oral cancer mortality in Europe. Oral Oncol. 2004, 40, 433-439.
2. Schliephake, H. Prognostic relevance of molecular markers of oral cancer - a review. Int. J. Oral Maxillofac. Surg. 2003, 32, 233-245.
3. Hunter, K. D.; Parkinson, E. K.; Harrison, P. R. Profiling early head and neck cancer. Nat. Rev. Cancer 2005, 5, 127-135.
4. Lothaire, P.; de Azambuja, E.; Dequanter, D.; Lalami, Y.; Sotiriou, C.; Andry, G.; Castro, G., Jr.; Awada, A. Molecular markers of head and neck squamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 2006, 28, 256-269.
5. He, Q. Y.; Chen, J.; Kung, H. F.; Yuen, A. P.; Chiu, J. F. Identification of tumor-associated proteins in oral tongue squamous cell carcinoma by proteomics. Proteomics 2004, 4, 271-278.
6. Chen, J.; He, Q. Y.; Yuen, A. P.; Chiu, J. F. Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 2004, 4, 2465-2475.
7. Vora, H. H.; Shah, N. G.; Patel, D. D.; Trivedi, T. I.; Chikhlikar, P. R. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J. Surg. Oncol. 2003, 82, 34-50.
8. Knezevic, V.; Leethanakul, C.; Bichsel, V. E.; Worth, J. M.; Prabhu, V. V.; Gutkind, J. S.; Liotta, L. A.; Munson, P. J.; Petricoin, E. F. 3rd; Krizman, D. B. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 2001, 1, 1271-1278.
9. Nassiri, M.; Nadji, M. Tissue detection of biomolecular predictors in breast cancer. Expert Rev. Anticancer Ther. 2006, 6, 1225-1232.
10. Freshney, I. R. In Culture of Epithelial Cells, 2nd ed.; Wiley-Liss, Inc.: New York, 2002.
11. Nakamura, T.; Fidler, I. J.; Coombes, K. R. Gene expression profile of metastatic human pancreatic cancer cells depends on the organ microenvironment. Cancer Res. 2007, 67, 139-148.
12. Grafström, R. C. In Culture of Epithelial Cells, 2nd ed.; John Wiley and Sons, Inc.: New York, 2002.
13. Edington, K. G.; Berry, I. J.; O'Prey, M.; Burns, J. E.; Clark, L. J.; Mitchell, R.; Robertson, G.; Soutar, D.; Coggins, L. W.; Parkinson, E. K. In Culture of Human Tumor Cells; John Wiley & Sons, Inc.: New Jersey, 2004.
14. Sundqvist, K.; Kulkarni, P.; Hybbinette, S. S.; Bertolero, F.; Liu, Y.; Grafström, R. C. Serum-free growth and karyotype analyses of cultured normal and tumorous (SqCC/Y1) human buccal epithelial cells. Cancer Commun. 1991, 3, 331-340.
15. Kulkarni, P. S.; Sundqvist, K.; Betsholtz, C.; Höglund, P.; Wiman, K. G.; Zhivotovsky, B.; Bertolero, F.; Liu, Y.; Grafström, R. C. Characterization of human buccal epithelial cells transfected with the simian virus 40 T-antigen gene. Carcinogenesis 1995, 16, 2515-2521.
16. Staab, C. A.; Vondracek, M.; Custodio, H.; Johansson, K.; Nilsson, J. A.; Morgan, P.; Höög, J. O.; Cotgreave, I.; Grafström, R. C. Modelling of normal and premalignant oral tissue by using the immortalised cell line, SVpgC2a: a review of the value of the model. Altern. Lab. Anim. 2004, 32, 401-405.
17. Hansson, A.; Bloor, B. K.; Haig, Y.; Morgan, P. R.; Ekstrand, J.; Grafström, R. C. Expression of keratins in normal, immortalized and malignant oral epithelia in organotypic culture. Oral Oncol. 2001, 37, 419-430.
18. Hansson, A.; Bloor, B. K.; Sarang, Z.; Haig, Y.; Morgan, P. R.; Stark, H. J.; Fusenig, N. E.; Ekstrand, J.; Grafström, R. C. Analysis of proliferation, apoptosis and keratin expression in cultured normal and immortalized human buccal keratinocytes. Eur. J. Oral Sci. 2003, 111, 34-41.
19. Vondracek, M.; Xi, Z.; Larsson, P.; Baker, V.; Mace, K.; Pfeifer, A.; Tjälve, H.; Donato, M. T.; Gomez-Lechon, M. J.; Grafström, R. C. Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 2001, 22, 481-488.
20. Vondracek, M.; Weaver, D. A.; Sarang, Z.; Hedberg, J. J.; Willey, J. C.; Wärngård, L.; Grafström, R. C. Transcript profiling of enzymes involved in detoxification of xenobiotics and reactive oxygen in human normal and simian virus 40 T antigen-immortalized oral keratinocytes. Int. J. Cancer 2002, 99, 776-782.
21. Reiss, M.; Brash, D. E.; Munoz-Antonia, T.; Simon, J. A.; Ziegler, A.; Vellucci, V. F.; Zhou, Z. L. Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines. Oncol. Res. 1992, 4, 349-357.
22. Greenbaum, D.; Jansen, R.; Gerstein, M. Analysis of mRNA expression and protein abundance data: an approach for the comparison of the enrichment of features in the cellular population of proteins and transcripts. Bioinformatics 2002, 18, 585-596.
23. Gygi, S. P.; Corthals, G. L.; Zhang, Y.; Rochon, Y.; Aebersold, R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 9390-9395.
24. Kuruma, H.; Egawa, S.; Oh-Ishi, M.; Kodera, Y.; Maeda, T. Proteome analysis of prostate cancer. Prostate Cancer Prostatic Dis. 2005, 8, 14-21.
25. Dietel, M.; Sers, C. Personalized, medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. A review. Virchows Arch. 2006, 448, 744-755.
26. Kang, D.; Suh, M.; Kang, C. Highly sensitive and fast protein detection with coomassie brilliant blue in sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Bull. Kor. Chem. Soc. 2002, 23, 1511-1512.
27. Roblick, U. J.; Hirschberg, D.; Habermann, J. K.; Palmberg, C.; Becker, S.; Krüger, S.; Gustafsson, M.; Bruch, H. P.; Franzen, B.; Ried, T.; Bergmann, T.; Auer, G.; Jörnvall, H. Sequential proteome alterations during genesis and progression of colon cancer. Cell. Mol. Life Sci. 2004, 61, 1246-1255.
28. Gustafsson, M.; Hirschberg, D.; Palmberg, C.; Jörnvall, H.; Bergman, T. Integrated sample preparation and MALDI mass spectrometry on a microfluidic compact disk. Anal. Chem. 2004, 76, 345-350.
29. Johansson, A. C.; Steen, H.; Öllinger, K.; Roberg, K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ. 2003, 10, 1253-1259.
30. Qi, Y.; Chiu, J. F.; Wang, L.; Kwong, D. L.; He, Q. Y. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 2005, 5, 2960-2971.
31. Yokoyama, Y.; Kuramitsu, Y.; Takashima, M.; Iizuka, N.; Toda, T.; Terai, S.; Sakaida, I.; Oka, M.; Nakamura, K.; Okita, K. Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus. Proteomics 2004, 4, 2111-2116.
32. Kang, H. J.; Koh, K. H.; Yang, E.; You, K. T.; Kim, H. J.; Paik, Y. K.; Kim, H. Differentially expressed proteins in gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics 2006, 6, 1151-1157.
33. Pino, I.; Pio, R.; Toledo, G.; Zabalegui, N.; Vicent, S.; Rey, N.; Lozano, M. D.; Torre, W.; Garcia-Foncillas, J.; Montuenga, L. M. Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer 2003, 41, 131-143.
34. Choi, J. H.; Kim, T. N.; Kim, S.; Baek, S. H.; Kim, J. H.; Lee, S. R.; Kim, J. R. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res. 2002, 22, 3331-3335.
35. Byrjalsen, I.; Mose Larsen, P.; Fey, S. J.; Nilas, L.; Larsen, M. R.; Christiansen, C. Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma. Mol. Hum. Reprod. 1999, 5, 748-756.
36. Morgan, P. R.; Su, L. Intermediate, filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia. Eur. J. Cancer B Oral Oncol. 1994, 30B, 160-166.
37. Vaidya, M. M.; Sawant, S. S.; Borges, A. M.; Ogale, S. B.; Bhisey, A. N. Cytokeratin expression in precancerous lesions of the human oral cavity. Oral Oncol. 1998, 34, 261-264.
38. Chu, P. G.; Weiss, L. M. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod. Pathol. 2002, 15, 6-10.
39. Cohen-Kerem, R.; Madah, W.; Sabo, E.; Rahat, M. A.; Greenberg, E.; Elmalah, I. Cytokeratin-17 as a potential marker for squamous cell carcinoma of the larynx. Ann. Otol. Rhinol. Latyngol. 2004, 113, 821-827.
40. Goto, Y.; Sueoka, E.; Chiba, H.; Fujiki, H. Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma. Jpn. J. Cancer Res. 1999, 90, 1358-1363.
41. Koike, H.; Uzawa, K.; Nakashima, D.; Shimada, K.; Kato, Y.; Higo, M.; Kouzu, Y.; Endo, Y.; Kasamatsu, A.; Tanzawa, H. Identification of differentially expressed proteins in oral squamous cell carcinoma using a global proteomic approach. Int. J. Oncol. 2005, 27, 59-67.
42. Perry, S. V. Vertebrate tropomyosin: distribution, properties and function. J. Muscle Res. Cell Motil. 2001, 22, 5-49.
43. Ciocca, D. R.; Calderwood, S. K. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 2005, 10, 86-103.
44. Harrison, P. M.; Arosio, P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1996, 1275, 161-203.
45. Hermeking, H.; Benzinger, A. 14-3-3 proteins in cell cycle regulation. Semin. Cancer Biol. 2006, 16, 183-192.
46. Macip, S.; Igarashi, M.; Berggren, P.; Yu, J.; Lee, S. W.; Aaronson, S. A. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol. Cell. Biol. 2003, 23, 8576-8585.
47. Chen, M. F.; Chen, W. C.; Wu, C. T.; Lin, P. Y.; Shau, H.; Liao, S. K.; Yang, C. T.; Lee, K. D. p53 status is a major determinant of effects of decreasing peroxiredoxin I expression on tumor growth and response of lung cancer cells to treatment. Int. J. Radiat. Oncol. Biol. Phys. 2006, 66, 1461-1472.
48. Immenschuh, S.; Baumgart-Vogt, E. Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid. Redox Signaling 2005, 7, 768-777.
49. Tian, Q.; Stepaniants, S. B.; Mao, M.; Weng, L.; Feetham, M. C.; Doyle, M. J.; Yi, E. C.; Dai, H.; Thorsson, V.; Eng, J.; Goodlett, D.; Berger, J. P.; Gunter, B.; Linseley, P. S.; Stoughton, R. B.; Aebersold, R.; Collins, S. J.; Hanlon, W. A.; Hood, L. E. Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol. Cell. Proteomics 2004, 3, 960-969.
50. Hu, P.; Bader, G.; Wigle, D. A.; Emili, A. Computational prediction of cancer-gene function. Nat. Rev. Cancer 2007, 7, 23-34.
51. Ginos, M. A.; Page, G. P.; Michalowicz, B. S.; Patel, K. J.; Volker, S. E.; Pambuccian, S. E.; Ondrey, F. G.; Adams, G. L.; Gaffney, P. M. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res. 2004, 64, 55-63.
52. Saranath, D.; Panchal, R. G.; Nair, R.; Mehta, A. R.; Sanghavi, V.; Sumegi, J.; Klein, G.; Deo, M. G. Oncogene amplification in squamous cell carcinoma of the oral cavity. Jpn. J. Cancer Res. 1989, 80, 430-437.
53. Field, J. K. The role of oncogenes and tumour-suppressor genes in the aetiology of oral, head and neck squamous cell carcinoma. J. R. Soc. Med. 1995, 88, 35P-39P.
54. Ohkura, S.; Kondoh, N.; Hada, A.; Arai, M.; Yamazaki, Y.; Sindoh, M.; Takahashi, M.; Matsumoto, I.; Yamamoto, M. Complex formations involving both SP-1 and SP-3 at the transcriptional regulatory sequence correlate with the activation of the Keratin 14 gene in human oral squamous cell carcinoma cells. Oncol. Rep. 2005, 14, 1577-1581.
55. Chen, Y. K.; Huse, S. S.; Lin, L. M. Differential expression of p53, p63 and p73 proteins in human buccal squamous-cell carcinomas. Clin. Otolaryngol. Allied Sci. 2003, 28, 451-455.
56. Schuster, M. B.; Porse, B. T. C/EBPalpha: a tumour suppressor in multiple tissues? Biochim. Biophys. Acta 2006, 1766, 88-103.
57. Lucas, B.; Grigo, K.; Erdmann, S.; Lausen, J.; Klein-Hitpass, L.; Ryffel, G. U. HNF4alpha reduces proliferation of kidney cells and affects genes deregulated in renal cell carcinoma. Oncogene 2005, 24, 6418-6431.
58. Miyamoto, K.; Fukutomi, T.; Akashi-Tanaka, S.; Hasegawa, T.; Asahara, T.; Sugimura, T.; Ushijima, T. Identification of 20 genes aberrantly methylated in human breast cancers. Int. J. Cancer 2005, 116, 407-414.
59. Folpe, A. L. MyoD1 and myogenin expression in human neoplasia: a review and update. Adv. Anat. Pathol. 2002, 9, 198-203.
60. Borghini, S.; Vargiolu, M.; Di, Duca, M.; Ravazzolo, R.; Ceccherini, I. Nuclear factor Y drives basal transcription of the human TLX3, a gene overexpressed in T-cell acute lymphocytic leukemia. Mol. Cancer Res. 2006, 4, 635-643.
61. Iamaroon, A.; Pattamapun, K.; Piboonniyom, S. O. Aberrant expression of Smad4, a TGF-beta signaling molecule, in oral squamous cell carcinoma. J. Oral Sci. 2006, 48, 105-109.
62. Bindhu, O. S.; Ramadas, K.; Sebastian, P.; Pillai, M. R. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma. Head Neck 2006, 28, 916-925.
63. Harris, G.; Ghazallah, R. A.; Nascene, D.; Wuertz, B.; Ondrey, F. G. PPAR activation and decreased proliferation in oral carcinoma cells with 4-HPR. Otolaryngol. Head Neck Surg. 2005, 133, 695-701.
64. Brennan, P. A.; Mackenzie, N.; Quintero, M. Hypoxia-inducible factor 1alpha in oral cancer. J. Oral Pathol. Med. 2005, 34, 385-389.
65. Shillitoe, E. J.; May, M.; Patel, V.; Lethanakul, C.; Ensley, J. F.; Strausberg, R. L.; Gutkind, J. S. Genome-wide analysis of oral cancer-early results from the Cancer Genome Anatomy Project. Oral Oncol. 2000, 36, 8-16.
66. Leethanakul, C.; Patel, V.; Gillespie, J.; Shillitoe, E.; Kellman, R. M.; Ensley, J. F.; Limwongse, V.; Emmert-Buck, M. R.; Krizman, D. B.; Gutkind, J. S. Gene expression profiles in squamous cell carcinomas of the oral cavity: use of laser capture microdissection for the construction and analysis of stage-specific cDNA libraries. Oral Oncol. 2000, 36, 474-483.
67. Leethanakul, C.; Knezevic, V.; Patel, V.; Amornphimoltham, P.; Gillespie, J.; Shillitoe, E. J.; Emko, P.; Park, M. H.; Emmert-Buck, M. R.; Strausberg, R. L.; Krizman, D. B.; Gutkind, J. S. Gene discovery in oral squamous cell carcinoma through the Head and Neck Cancer Genome Anatomy Project: confirmation by microarray analysis. Oral Oncol. 2003, 39, 248-258.
68. Hanahan, D.; Weinberg, R. A. The hallmarks of cancer. Cell 2000, 100, 57-70.
69. Wang, T.; Xu, J.; Yu, X.; Yang, R.; Han, Z. C. Peroxisome proliferator-activated receptor gamma in malignant diseases. Crit. Rev. Oncol. Hematol. 2006, 58, 1-14.
70. Brenner, L.; Munoz-Antonia, T.; Vellucci, V. F.; Zhou, Z. L.; Reiss, M. Wild-type p53 tumor suppressor gene restores differentiation of human squamous carcinoma cells but not the response to transforming growth factor beta. Cell Growth Differ. 1993, 4, 993-1004.